Neoadjuvant Chemoimmunotherapy Boosts Stage III Lung Cancer Outcomes
In a groundbreaking advancement for the treatment of stage III locally advanced non-small cell lung cancer (NSCLC), recent research highlights the promising clinical benefits of...